AD Roth

3.4k citations
4 papers · 2.7k · 1 hit paper · h-index 3

Impact in

  • Oncology top 1%
    • Colorectal Cancer Treatments and Studies
    • Colorectal Cancer Surgical Treatments
    • Pharmacogenetics and Drug Metabolism

Papers in

AD Roth

4 papers receiving 2.6k citations

AD Roth's Hit Papers

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial 2000 · 2.7k citations
2.7k0+8+17Years since publication5001k1.5k2k2.5k

Peers

AD Roth
Comparison fields: 5 of 80
  • Oncology 2k
  • Pharmacology 139
  • Hepatology 84
  • Molecular Biology 359
  • Geriatrics and Gerontology 18
Replace G. Gruia with:
G. Gruia France
Nicoletta Pirotta United States
Paula K. Locker United States
C. Wilson United Kingdom
Michel Homerin France
Daniel Hendler Israel
Petr Karásek Czechia
J-Y Douillard France
Daniel L Mulkerin United States
Lucile Awad France
AD Roth relative to G. Gruia France G. Gruia's profile →
Citations per field
00.5×1.5×
G. Gruia · 1×
Citations per year

Countries citing papers authored by AD Roth

Since Specialization
Citations

This map shows the geographic impact of AD Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AD Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AD Roth more than expected).

Fields of papers citing papers by AD Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AD Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AD Roth. The network helps show where AD Roth may publish in the future.

Co-authors

The 15 scholars most cited alongside AD Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with AD Roth Line = papers co-authored together AD Roth links everyone, so they are left out of the graph.

All Works

4 of 4 papers shown
#Work
1
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
Hit paper breakdown →
20002717
2 20116
3
Selecting for clinical training
19954
4
Getting on clinical training courses
19983

About AD Roth

AD Roth is a scholar working on Public Health, Environmental and Occupational Health, Oncology, Pulmonary and Respiratory Medicine, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 4 papers that have together received 2.7k indexed citations. Recurring topics across this work include Medical Education and Admissions (2 papers), Colorectal Cancer Treatments and Studies (1 paper), Innovations in Medical Education (1 paper), Gastric Cancer Management and Outcomes (1 paper) and Health and Medical Research Impacts (1 paper). The work is most often cited by research in Oncology (2k citations), Pharmacology (139 citations), Hepatology (84 citations), Molecular Biology (359 citations) and Geriatrics and Gerontology (18 citations). AD Roth has collaborated with scholars based in Spain, Czechia and Switzerland. Frequent co-authors include May Klink Alakl, Pavel Jandík, Matilde Navarro, J Carmichael, Petr Karásek, J-Y Douillard, Timothy J. Iveson, G. Gruia, David Cunningham and Philippe R Rougier. Their work appears in journals such as The Lancet, Swiss Medical Weekly and UCL Discovery (University College London).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact